Screening og intervention: En strategi ved type 2-diabetes?

Torben Jørgensen*, Charlotte Glümer, Knut Borch-Johnsen

*Corresponding author af dette arbejde

    Publikation: Bidrag til tidsskriftArtikelForskningpeer review


    Before the introduction of screening for type 2 diabetes, it is necessary to evaluate not only the technology, but also the patient perspective, the economical consequences, and the organising aspects. A review of the relevant literature shows that type 2 diabetes is a rapidly increasing, serious disease. However, there is no documentation that systematic screening will have a positive effect on morbidity and mortality, owing to the lack of randomised clinical trials. The methods for screening could be optimised, and there is a lack of literature on patient perspective. Economical models indicate that opportunistic screening is more cost-effective than is systematic screening, but the lack of randomised trials makes the conclusion dubious. A decision to introduce systematic screening for type 2 diabetes should await the results of ongoing randomised clinical trials. In the meantime, efforts should be spent on improving the level of care for those already diagnosed with diabetes.

    Bidragets oversatte titelScreening and intervention: A strategy in type 2 diabetes?
    Sider (fra-til)2135-2139
    Antal sider5
    TidsskriftUgeskrift for laeger
    Udgave nummer16
    StatusUdgivet - 15 apr. 2002


    Udforsk hvilke forskningsemner 'Screening og intervention: En strategi ved type 2-diabetes?' indeholder.